Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
Tesla CEO Elon Musk credits it with his dramatic weight loss
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes that was subsequently found to produce substantial weight loss
HbA1C reductions ranged from 1.2% to 1.8% depending on dose and baseline glycemia
Available in a prefilled, single-dose pen, the therapy can be self-administered with appropriate training
Its level decreases with age (especially from the age of 45-50) and as the body's defence needs increase (immunity, liver detoxification, antioxidant defences...)
US$ 29.59
US$ 23.88
US$ 22.78
US$ 21.25
US$ 21.14
